COVID-19 vaccine: BioNTech and Pfizer report 90% effectiveness in trials

10 November 2020
475 Views

Germany’s BioNTech and its US pharma partner Pfizer announced on Monday that their vaccine candidate is more than 90% effective in preventing COVID-19 in a trial of over 43,000 participants.

“Today is a great day for science and humanity,“ said Dr Albert Bourla, chairman and CEO of Pfizer in a statement. “The first set of results from our Phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent Covid-19.”

Based on current projections from the company, it expects to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021.

Pfizer and BioNTech plan to submit data from the full Phase 3 trial for scientific peer-review publication.

Bourla said that they are “reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen”.

Source: yahoo

You may be interested

Odysseus’s Ithaca – Five beautiful beaches you must visit
GREECE
shares26 views
GREECE
shares26 views

Odysseus’s Ithaca – Five beautiful beaches you must visit

Panos - Jul 27, 2021

Ithaca is one of those hidden gems that Greece has to offer the inquiring traveller. The island, known as the…

Turkish businessman pays €76,000 fine in Mykonos for Covid-19 violation on yacht (video)
FINANCE
shares43 views
FINANCE
shares43 views

Turkish businessman pays €76,000 fine in Mykonos for Covid-19 violation on yacht (video)

Panos - Jul 27, 2021

A Turkish yacht owner paid a total of €76,000 for violating Covid-19 regulations in Mykonos. The businessman was fined for…

Weather Greece: 10-day heatwave coming
GREECE
shares23 views
GREECE
shares23 views

Weather Greece: 10-day heatwave coming

Panos - Jul 27, 2021

A 10-day heatwave starts in western Greece today with temperatures that will reach and exceed 40 degrees Celsius. Meteorologists warn…

Leave a Comment

Your email address will not be published.